Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study

Autor: M. Otiende, A. Nyaguara, C. Bottomley, D. Walumbe, G. Mochamah, D. Amadi, C. Nyundo, E. W. Kagucia, A. O. Etyang, I. M. O. Adetifa, S. P. C. Brand, E. Maitha, E. Chondo, E. Nzomo, R. Aman, M. Mwangangi, P. Amoth, K. Kasera, W. Ng’ang’a, E. Barasa, B. Tsofa, J. Mwangangi, P. Bejon, A. Agweyu, T. N. Williams, J. A. G. Scott

Publikováno v: Nature Communications, Vol 14, Iss 1, Pp 1-9 (2023)

Abstract The mortality impact of COVID-19 in Africa remains controversial because most countries lack vital registration. We analysed excess mortality in Kilifi Health and Demographic Surveillance System, Kenya, using 9 years of baseline data. SARS-C

Externí odkaz: https://doaj.org/article/54fdadaf9c2342018724794e6a658265

Monitoring biodiversity loss in rapidly changing Afrotropical ecosystems: an emerging imperative for governance and research

Autor: A. O. Achieng, G. B. Arhonditsis, N. Mandrak, C. Febria, B. Opaa, T. J. Coffey, F. O. Masese, K. Irvine, Z. M. Ajode, K. Obiero, J. E. Barasa, B. Kaunda-Arara

Publikováno v: Philosophical Transactions of the Royal Society B: Biological Sciences. 378

Africa is experiencing extensive biodiversity loss due to rapid changes in the environment, where natural resources constitute the main instrument for socioeconomic development and a mainstay source of livelihoods for an increasing population. Lack o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d60fcd9089f5e76a8d8554c31b5294ef
https://doi.org/10.1098/rstb.2022.0271

Prevalence of Trachomatous Trichiasis in Ten Evaluation Units of Embu and Kitui Counties, Kenya

Autor: D, Ilako, E, Barasa, M, Gichangi, S, Mwatha, T, Watitu, J, Bore, A, Rajamani, R, Butcher, R M, Flueckiger, A, Bakhtiari, R, Willis, A W, Solomon, E M, Harding-Esch, S H, Matendechero

Publikováno v: Ophthalmic Epidemiology. :1-8

BACKGROUND: Late-stage blinding sequalae of trachoma such as trachomatous trichiasis (TT) typically take decades to develop and often do so in the absence of ongoing ocular Chlamydia trachomatis infection. This suggests that most TT risk accumulates

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b447401d82d42a10a72de2d518fd4985
https://doi.org/10.1080/09286586.2021.1986549

Effects of the COVID-19 pandemic on hospital admissions and inpatient mortality in Kenya

Autor: M Ogero, L Isaaka, L Mumelo, D Kimego, T Njoroge, G Mbevi, C Wanyama, R Lucinde, H Gathuri, M Otiende, C Nzioki, A Wachira, F Mumbi, G Oeri, N Mwangi, R Gitari, D Mugambi, S Namu, A Ithondeka, H Kariuki, Z Kiama, L Mwende, E Jowi, B Muthui, A Kaara, E Sitienei, L Thuranira, I Oginga, J Njagi, E Kamau, E Namulala, G Oketch, O Wandera, S Adhiambo, A Adem, M Ochieng, A Otedo, K Otiende, A Odondi, F Makokha, D Lubanga, J Nyikui, W Masoso, M Manyonge, R Inginia, E Manuthu, D Wafula, C Agutu, R Malangachi, S Biko, null Simiyu, J Obare, D Kimutai, B Gituma, J Kyalo, M Timbwa, J Otieno, M Liru, C Nyabinda, S Otieno, R Aman, M Mwangangi, P Amoth, I Were, C Mwangi, K Kasera, W Ng’ang’a, A Tsegaye, C Sherry, B Singa, K Tickell, J Walson, J Berkley, F Were, N Mturi, M Hamaluba, B Tsofa, J Mwangangi, P Bejon, E Barasa, M English, A Nyaguara, EW Kagucia, JAG Scott, S Akech, AO Etyang, A Agweyu

BackgroundThe impact of COVID-19 in Africa remains poorly defined. We sought to describe trends in hospitalisation due to all medical causes, pneumonia-specific admissions, and inpatient mortality in Kenya before and during the first five waves of th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::13ed55b049c0ce09cdcd508f65c965c3
https://doi.org/10.1101/2022.10.25.22281489

SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022

Autor: EW Kagucia, AK Ziraba, J Nyagwange, B Kutima, M Kimani, D Akech, M Ng’oda, A Sigilai, D Mugo, H Karanja, J Gitonga, A Karani, M Toroitich, B Karia, M Otiende, A Njeri, R Aman, P Amoth, M Mwangangi, K Kasera, W Ng’ang’a, S Voller, LI Ochola-Oyier, C Bottomley, A Nyaguara, PK Munywoki, G Bigogo, E Maitha, S Uyoga, KE Gallagher, AO Etyang, E Barasa, J Mwangangi, P Bejon, IMO Adetifa, GM Warimwe, JAG Scott, A Agweyu

BackgroundUp-to-date SARS-CoV-2 antibody seroprevalence estimates are important for informing public health planning, including priorities for Coronavirus disease 2019 (COVID-19) vaccination programs. We sought to estimate infection- and vaccination-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c531afb244189bf265efbbf1b2abeb13
https://doi.org/10.1101/2022.10.10.22280824